Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-030131
Filing Date
2019-12-27
Accepted
2019-12-27 20:00:17
Documents
1
Period of Report
2019-12-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4917
  Complete submission text file 0000899243-19-030131.txt   6510
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 191314620